-
-
-
-
-
-
-
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
-
-
-
-
-
-
-
Medicus Pharma gets FDA clearance for Teverelix prostate cancer study
-
-
-
-
-
-
-
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women
-
-
-
-
-
-
-
Medicus Pharma enters $5.1 million warrant inducement agreement
-
-
-
-
-
-
-
Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
-
-
-
-
-
-
-
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
-
-
-
-
-
-
-
The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets
-
1,178,437 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

